Breaking News Instant updates and real-time market news.

VIAB

Viacom

$23.74

-0.35 (-1.45%)

, VIA

Viacom

$26.16

0.06 (0.23%)

16:56
12/02/19
12/02
16:56
12/02/19
16:56

News Corp names David Kline CTO

News Corp (NWSA) announced that David Kline will become Chief Technology Officer, beginning in January. He will succeed Marc Frons, who has held the post since 2016. Kline joins News Corp from Viacom (VIAB), where he served as CTO since 2010. "David Kline is expert at driving innovation and efficiency in businesses that distribute quality content worldwide," said Robert Thomson, Chief Executive of News Corp. "He is the ideal person to take the baton from Marc Frons, who has ably and thoughtfully been leading the technological transformation of News Corp since his arrival four years ago. We have robust global shared technology services and are rapidly establishing efficient platforms for everything from security and data to mobile apps."

VIAB

Viacom

$23.74

-0.35 (-1.45%)

VIA

Viacom

$26.16

0.06 (0.23%)

NWSA

News Corp.

$12.89

0.01 (0.08%)

NWS

News Corp

$13.18

0.01 (0.08%)

  • 09

    Dec

  • 12

    Dec

  • 13

    Dec

VIAB Viacom
$23.74

-0.35 (-1.45%)

11/18/19
LEHM
11/18/19
NO CHANGE
LEHM
Equal Weight
CBS, Viacom risk/rewards attractive in near-term, says Barclays
While CBS (CBS) and Viacom (VIAB) have underperformed broader markets and media peers significantly since announcing their merger deal, there could be some near-term catalysts to provide support post the deal close, Barclays analyst Kannan Venkateshwar tells investors in a research note. CBS's December renewal with YouTube will not only provide an opportunity to add some Viacom networks to YouTube TV, but success in doing so could also help narrative on revenue synergies, contends the analyst. Further, he believes both companies "could have some coterminous affiliate deals next year that could further add to this story." In addition, digital revenue is starting to be "meaningful in scale" from a revenue perspective for both companies, contends Venkateshwar. As such, he believes shares of CBS and Viacom offer attractive risk/rewards in the near term, despite lacking long term visibility. The analyst keeps Equal Weight ratings on both names.
10/24/19
FBCO
10/24/19
NO CHANGE
Target $52
FBCO
Outperform
CBS price target lowered to $52 from $66 at Credit Suisse
Credit Suisse analyst Douglas Mitchelson lowered his price target for CBS (CBS) to $52 from $66 after reviewing the ViacomCBS S-4 merger filing in detail and considering post-merger announcement management commentary. The analyst does not believe the S-4 disclosures for the separate CBS and Viacom (VIAB) budgets represent the outlook for the combined company based on the likely operating strategies of ViacomCBS management. Further, Mitchelson believes management's focus on programming efficiencies and undertaking only modest investments in streaming services suggests the programming/working capital budgets in the S-4 were too high. He reiterates an Outperform rating on CBS shares.
10/23/19
WELS
10/23/19
NO CHANGE
Target $31
WELS
Underperform
CBS price target lowered to $31 from $40 at Wells Fargo
Wells Fargo analyst Steven Cahall lowered his price target for Underperform-rated CBS (CBS) to $31 from $40, saying the Viacom (VIAB)-CBS S-4 has further reduced his investor confidence. HE tells investors that CBS investors are "frustrated" that it took so long to reset expectations to a new lower normal. The analyst also lowered his price target for Viacom to $23 from $18, saying management's projections in the out years appear disconnected from ecosystem realities.
10/21/19
LEHM
10/21/19
NO CHANGE
Target $41
LEHM
Equal Weight
Barclays cuts CBS target to $41, Viacom target to $24
Barclays analyst Kannan Venkateshwar cut his price target for CBS (CBS) to $41 from $53 and for Viacom (VIAB) to $24 from $33 while keeping Equal Weight ratings on both names. CBS and Viacom shares have sold off ~25% since their merger announcement on August 13, partly due to deal technicals, Venkateshwar tells investors in a research note. However, the analyst believes the selloffs are also a reflection of the fundamental challenges faced by both companies and skepticism around upside from the deal. The S-4 filing last week is the latest evidence of this struggle with CBS cutting its free cash flow estimates for the next couple years by 30%-40% and Viacom cutting EBITDA by 7%-8% versus consensus, Venkateshwar says. As a result of this revision, CBS may miss its long-term standalone earnings and revenue growth guidance provided at the beginning of this year, he adds.
VIA Viacom
$26.16

0.06 (0.23%)

09/24/19
09/24/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Disney (DIS) was initiated with an Outperform at Wells Fargo, while Netflix (NFLX) was initiated with a Market Perform, and CBS (CBS), Viacom (VIAB, VIA), and Fox Corp. (FOXA) were initiated with Underperform ratings. 2. Merit Medical (MMSI) initiated with an Outperform at Oppenheimer. 3. Global Payments (GPN) reinstated with a Buy at Goldman Sachs. 4. 10x Genomics (TXG) initiated with an Outperform at Evercore ISI. 5. Corcept Therapeutics (CORT) and Strongbridge Biopharma (SBBP) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/14/19
DBAB
08/14/19
UPGRADE
DBAB
Buy
Viacom upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Bryan Kraft upgraded Viacom (VIAB) to Buy from Hold and raised his price target on the stock to $42 from $33. Yesterday, CBS (CBS) and Viacom announced a definitive agreement to combine in an all-stock merger.
NWSA News Corp.
$12.89

0.01 (0.08%)

08/11/19
FBCO
08/11/19
UPGRADE
FBCO
Outperform
News Corp. upgraded to Outperform from Neutral at Credit Suisse
07/19/19
07/19/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. SAP (SAP) downgraded to Hold from Buy at Deutsche Bank with analyst Alex Tout saying he believes the company's momentum in Q2 fell short of what was needed for the shares to re-rate higher. 2. Alcoa (AA) downgraded to Hold from Buy at Argus and Jefferies. 3. Paycom (PAYC) downgraded to Hold from Buy at Jefferies with analyst Samad Samana citing valuation. 4. Michaels (MIK) downgraded to Underperform from Neutral at BofA/Merrill with analyst Elizabeth Suzuki citing a U.S. arts and crafts consumer survey that she said gave some color on why the company's same-store sales growth has been "lackluster. 5. News Corp. (NWSA) downgraded to Underweight from Neutral at JPMorgan with analyst Alexia Quadrani saying while the stock may appear attractively valued, she has little conviction in forward estimates. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/19
JPMS
07/19/19
DOWNGRADE
Target $12
JPMS
Underweight
JPMorgan downgrades News Corp. to Underweight, cuts price target to $12
JPMorgan analyst Alexia Quadrani last night downgraded News Corp. to Underweight from Neutral and lowered her price target for the shares to $12 from $13. The analyst says that while the stock may appear attractively valued, she has little conviction in forward estimates. Quadrani, who points out she's reduced News Corp.'s estimates 12 times over the last three years, believes challenges will persist in the company's News and Information Services and Subscription Video Services divisions. Further, she sees weakness in new listings at REA and "further headwinds to growth continuing." The analyst looks for stabilization in her estimates or signs of strategic change as catalysts to reevaluate her rating.
07/18/19
JPMS
07/18/19
DOWNGRADE
Target $12
JPMS
Underweight
News Corp. downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Alexia Quadrani downgraded News Corp. to Underweight from Neutral and lowered her price target for the shares to $12 from $13.
NWS News Corp
$13.18

0.01 (0.08%)

TODAY'S FREE FLY STORIES

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

16:53
12/05/19
12/05
16:53
12/05/19
16:53
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMN

Eastman Chemical

$75.68

0.67 (0.89%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Hot Stocks
Eastman Chemical raises quarterly dividend 6.5% to 66c from 62c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVRI

Everi Holdings

$11.86

-1 (-7.78%)

16:43
12/05/19
12/05
16:43
12/05/19
16:43
Syndicate
Everi Holdings 10M share Secondary priced at $11.25 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:39
12/05/19
12/05
16:39
12/05/19
16:39
Earnings
Zumiez raises FY19 SSS growth view to 4.0%-4.5% from prior view 2.0%-4.0% »

Based upon better than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:38
12/05/19
12/05
16:38
12/05/19
16:38
Earnings
Crowdstrike raises FY20 EPS view to (53c)-(52c) from (65c)-(62c) »

Consensus (63c). Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

FNHC

Federated National

$15.37

-0.04 (-0.26%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Hot Stocks
Federated National announces new $10M share repurchase program »

Federated National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:36
12/05/19
12/05
16:36
12/05/19
16:36
Earnings
Crowdstrike sees Q4 adjusted EPS (9c)-(8c), consensus (11c) »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Earnings
Crowdstrike reports Q3 adjusted EPS (7c), consensus (11c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

EPZM

Epizyme

$15.32

-0.48 (-3.04%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Upgrade
Epizyme rating change  »

Epizyme upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 18

    Dec

  • 23

    Jan

ESTA

Establishment Labs

$24.31

0.32 (1.33%)

16:35
12/05/19
12/05
16:35
12/05/19
16:35
Hot Stocks
Establishment Labs reaches one million Motiva implants milestone »

Establishment Labs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDT

IDT Corp

$7.47

0.26 (3.61%)

16:34
12/05/19
12/05
16:34
12/05/19
16:34
Earnings
IDT Corp reports Q1 EPS 10c vs. (2c) last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

KODK

Kodak

$2.59

0.085 (3.39%)

16:33
12/05/19
12/05
16:33
12/05/19
16:33
Hot Stocks
Kodak's Karfunkel acquires over 4.4M common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAC

GAP Airports

$99.66

-1.12 (-1.11%)

16:32
12/05/19
12/05
16:32
12/05/19
16:32
Hot Stocks
GAP Airports reports November traffic up 10.1% »

GAP Airports announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JOE

Saint Joe Co.

$19.49

0.7 (3.73%)

16:32
12/05/19
12/05
16:32
12/05/19
16:32
Hot Stocks
St. Joe, HomeCorp to build additional 120 apartment homes in Panama City Beach »

The St. Joe Company and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.44

-0.17 (-0.87%)

16:32
12/05/19
12/05
16:32
12/05/19
16:32
Hot Stocks
Alector announces FDA fast track designation granted to AL001 for dementia »

Alector announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGLN

Magellan Health

$76.79

-0.12 (-0.16%)

16:31
12/05/19
12/05
16:31
12/05/19
16:31
Hot Stocks
Magellan Health names James Murray as President and COO »

Magellan Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWIR

Sierra Wireless

$9.15

0.12 (1.33%)

16:31
12/05/19
12/05
16:31
12/05/19
16:31
Hot Stocks
Sierra Wireless CFO Dave McLennan retiring in mid-2020 »

Sierra Wireless CFO Dave…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

ASR

Asur

$167.79

-1.88 (-1.11%)

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Hot Stocks
Asur reports total November passenger traffic up 7.3% »

Asur announced that total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXNX

Axonics

$25.05

0.92 (3.81%)

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Hot Stocks
Integrated Core Strategies reports 5.1% passive stake in Axonics »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COO

Cooper Companies

$313.10

1 (0.32%)

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Earnings
Cooper Companies sees Q1 EPS $2.65-$2.75, consensus $2.97 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

16:30
12/05/19
12/05
16:30
12/05/19
16:30
Options
Preliminary option volume of 14.7M today »

Preliminary option volume…

COO

Cooper Companies

$312.96

0.86 (0.28%)

16:28
12/05/19
12/05
16:28
12/05/19
16:28
Earnings
Cooper Companies sees FY20 EPS $12.60-$13.30, consensus $13.10 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

  • 13

    Dec

BOLD

Audentes Therapeutics

$59.19

-0.09 (-0.15%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

16:27
12/05/19
12/05
16:27
12/05/19
16:27
Downgrade
Audentes Therapeutics, Astellas Pharma rating change  »

Audentes Therapeutics…

BOLD

Audentes Therapeutics

$59.19

-0.09 (-0.15%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:27
12/05/19
12/05
16:27
12/05/19
16:27
Earnings
Zumiez provides Q4 quarter to date sales update »

With the Thanksgiving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

ZUMZ

Zumiez

$30.63

0.67 (2.24%)

16:26
12/05/19
12/05
16:26
12/05/19
16:26
Earnings
Zumiez sees FY19 EPS $2.38- $2.46, consensus $2.16 »

Based upon better than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.